Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1987 Apr;68(1):33–38.

Immune response to oral polio vaccine in patients with IgA glomerulonephritis.

P O Leinikki 1, J Mustonen 1, A Pasternack 1
PMCID: PMC1542685  PMID: 2820631

Abstract

Oral poliovirus vaccine was used to immunize 51 patients with IgA glomerulonephritis and 44 healthy controls. The patients showed an enhanced antibody response compared to controls. This was apparent in a higher frequency of strong increases in neutralizing antibody titres during the course of immunization as well as higher levels of virus-specific IgA-class antibodies. IgG-class antibodies showed similar activity in both groups. In patients the neutralizing antibodies correlated with the virus-specific IgA-class antibodies, suggesting that the IgA-antibodies synthesized by the patients are functionally competent antibodies.

Full text

PDF
33

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bene M. C., Faure G., Duheille J. IgA nephropathy: characterization of the polymeric nature of mesangial deposits by in vitro binding of free secretory component. Clin Exp Immunol. 1982 Mar;47(3):527–534. [PMC free article] [PubMed] [Google Scholar]
  2. Egido J., Blasco R., Sancho J., Lozano L. T-cell dysfunctions in IgA nephropathy: specific abnormalities in the regulation of IgA synthesis. Clin Immunol Immunopathol. 1983 Feb;26(2):201–212. doi: 10.1016/0090-1229(83)90138-1. [DOI] [PubMed] [Google Scholar]
  3. Emancipator S. N., Gallo G. R., Lamm M. E. Experimental IgA nephropathy induced by oral immunization. J Exp Med. 1983 Feb 1;157(2):572–582. doi: 10.1084/jem.157.2.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Endoh M., Suga T., Miura M., Tomino Y., Nomoto Y., Sakai H. In vivo alteration of antibody production in patients with IgA nephropathy. Clin Exp Immunol. 1984 Sep;57(3):564–570. [PMC free article] [PubMed] [Google Scholar]
  5. Lamm M. E., Emancipator S. N., Gallo G. R. Relevance of an experimental model to clinical IgA nephropathy. Contrib Nephrol. 1984;40:32–36. doi: 10.1159/000409724. [DOI] [PubMed] [Google Scholar]
  6. Mustonen J., Pasternack A., Helin H., Nikkilä M. Clinicopathologic correlations in a series of 143 patients with IgA glomerulonephritis. Am J Nephrol. 1985;5(3):150–157. doi: 10.1159/000166925. [DOI] [PubMed] [Google Scholar]
  7. Pasternack A., Mustonen J., Leinikki P. Humoral immune response in patients with IgA and IgM glomerulonephritis. Clin Exp Immunol. 1986 Jan;63(1):228–233. [PMC free article] [PubMed] [Google Scholar]
  8. Sakai H., Endoh M., Tomino Y., Nomoto Y. Increase of IgA specific helper T alpha cells in patients with IgA nephropathy. Clin Exp Immunol. 1982 Oct;50(1):77–82. [PMC free article] [PubMed] [Google Scholar]
  9. Sancho J., Egido J., Rivera F., Hernando L. Immune complexes in IgA nephropathy: presence of antibodies against diet antigens and delayed clearance of specific polymeric IgA immune complexes. Clin Exp Immunol. 1983 Oct;54(1):194–202. [PMC free article] [PubMed] [Google Scholar]
  10. Tomino Y., Sakai H., Miura M., Endoh M., Nomoto Y. Detection of polymeric IgA in glomeruli from patients with IgA nephropathy. Clin Exp Immunol. 1982 Aug;49(2):419–425. [PMC free article] [PubMed] [Google Scholar]
  11. Turunen H., Vuorio K. A., Leinikki P. O. Determination of IgG, IgM and IgA antibody responses in human toxoplasmosis by enzyme-linked immunosorbent assay (ELISA). Scand J Infect Dis. 1983;15(3):307–311. doi: 10.3109/inf.1983.15.issue-3.12. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES